| 000 | 01694 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516155149.0 | ||
| 264 | 0 | _c20140501 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1440-1681 | ||
| 024 | 7 |
_a10.1111/1440-1681.12144 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrakash, Atish | |
| 245 | 0 | 0 |
_aPioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in the d-galactose-induced mouse model. _h[electronic resource] |
| 260 |
_bClinical and experimental pharmacology & physiology _cSep 2013 |
||
| 300 |
_a644-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xmetabolism |
| 650 | 0 | 4 |
_aAging _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGalactose _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMemory _xdrug effects |
| 650 | 0 | 4 |
_aMemory Disorders _xchemically induced |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPPAR gamma _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
| 700 | 1 | _aKumar, Anil | |
| 773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 40 _gno. 9 _gp. 644-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1440-1681.12144 _zAvailable from publisher's website |
| 999 |
_c22861775 _d22861775 |
||